Stock listing
Square Pharmaceuticals Plc
Selected listing: SQURPHARMA · DSEBD · BDT · BD
Square Pharmaceuticals Plc (DSEBD:SQURPHARMA), Health Technology. Latest release Apr 29, 2026: SQURPHARMA: Strong revenue and profit growth, with higher EPS…
- Ticker
- DSEBD:SQURPHARMA
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- DSEBD
- Currency
- BDT
About Square Pharmaceuticals Plc
Square Pharmaceuticals Plc, traded under the ticker SQURPHARMA, is a leading public company based in Bangladesh. The company focuses on producing a wide range of pharmaceutical products to meet the healthcare needs of the region.
Latest news from Square Pharmaceuticals Plc
SQURPHARMA: Strong revenue and profit growth, with higher EPS and robust operating cash flow
April 29, 2026
SQURPHARMA: Six-month net profit surged 16% year-over-year on strong revenue and cash flow growth
January 29, 2026
SQURPHARMA: Consolidated profit up 14.54% with strong exports and a 120% cash dividend; standalone profit dipped
November 20, 2025
SQURPHARMA: Net revenue grew 21.7% and net profit after tax rose 21.5% year-over-year in Q1 FY2025-26
November 12, 2025
SQURPHARMA: Double-digit profit and revenue growth, strong balance sheet, and robust investment income
April 29, 2025
Research Square Pharmaceuticals Plc
Square Pharmaceuticals Plc company profile
View the public company page for Square Pharmaceuticals Plc on 6ix.
Square Pharmaceuticals Plc news
Read company news and market updates connected to Square Pharmaceuticals Plc.
Square Pharmaceuticals Plc investor events
Find investor webinars, events, and replay context for Square Pharmaceuticals Plc.